HENDERSON MICHAEL THOMAS
Director
CIK: 1779990
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 8, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 33,513 | $73.72 | $2,470,578.36 | View Details Filing |
| May 8, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 24,814 | $74.76 | $1,855,094.64 | View Details Filing |
| May 8, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 19,269 | $75.35 | $1,451,919.15 | View Details Filing |
| May 8, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 2,404 | $72.57 | $174,458.28 | View Details Filing |
| Apr 8, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 200 | $85.00 | $17,000.00 | View Details Filing |
| Apr 8, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 2,000 | $83.26 | $166,520.00 | View Details Filing |
| Apr 8, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 17,800 | $82.48 | $1,468,144.00 | View Details Filing |
| Mar 11, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 8,363 | $74.29 | $621,287.27 | View Details Filing |
| Mar 11, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 8,219 | $74.83 | $615,027.77 | View Details Filing |
| Mar 11, 2026 | Apogee Therapeutics, Inc. (APGE) | S | 3,418 | $75.86 | $259,289.48 | View Details Filing |